THERMO FISHER SCIENTIFIC INC (TN8.DE) Fundamental Analysis & Valuation

FRA:TN8 • US8835561023

410.75 EUR
-3.4 (-0.82%)
Last: Mar 13, 2026, 07:00 PM

This TN8.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, TN8 scores 4 out of 10 in our fundamental rating. TN8 was compared to 22 industry peers in the Life Sciences Tools & Services industry. TN8 has an average financial health and profitability rating. TN8 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. TN8.DE Profitability Analysis

1.1 Basic Checks

  • In the past year TN8 was profitable.
  • In the past year TN8 had a positive cash flow from operations.
  • Each year in the past 5 years TN8 has been profitable.
  • Each year in the past 5 years TN8 had a positive operating cash flow.
TN8.DE Yearly Net Income VS EBIT VS OCF VS FCFTN8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • TN8's Return On Assets of 6.08% is in line compared to the rest of the industry. TN8 outperforms 59.09% of its industry peers.
  • The Return On Equity of TN8 (12.55%) is better than 68.18% of its industry peers.
  • TN8 has a Return On Invested Capital (6.00%) which is comparable to the rest of the industry.
  • TN8 had an Average Return On Invested Capital over the past 3 years of 6.18%. This is significantly below the industry average of 14.22%.
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROIC 6%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)6.18%
ROIC(5y)6.93%
TN8.DE Yearly ROA, ROE, ROICTN8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • TN8's Profit Margin of 15.05% is fine compared to the rest of the industry. TN8 outperforms 63.64% of its industry peers.
  • TN8's Profit Margin has declined in the last couple of years.
  • TN8's Operating Margin of 18.19% is fine compared to the rest of the industry. TN8 outperforms 63.64% of its industry peers.
  • In the last couple of years the Operating Margin of TN8 has declined.
  • With a Gross Margin value of 41.09%, TN8 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TN8 has declined.
Industry RankSector Rank
OM 18.19%
PM (TTM) 15.05%
GM 41.09%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-1.04%
GM growth 5Y-3.78%
TN8.DE Yearly Profit, Operating, Gross MarginsTN8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

5

2. TN8.DE Health Analysis

2.1 Basic Checks

  • TN8 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TN8 has less shares outstanding
  • The number of shares outstanding for TN8 has been reduced compared to 5 years ago.
  • TN8 has a worse debt/assets ratio than last year.
TN8.DE Yearly Shares OutstandingTN8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
TN8.DE Yearly Total Debt VS Total AssetsTN8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • TN8 has an Altman-Z score of 3.42. This indicates that TN8 is financially healthy and has little risk of bankruptcy at the moment.
  • TN8 has a Altman-Z score (3.42) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of TN8 is 6.26, which is on the high side as it means it would take TN8, 6.26 years of fcf income to pay off all of its debts.
  • TN8 has a Debt to FCF ratio (6.26) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that TN8 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of TN8 (0.67) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Altman-Z 3.42
ROIC/WACC0.58
WACC10.43%
TN8.DE Yearly LT Debt VS Equity VS FCFTN8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that TN8 should not have too much problems paying its short term obligations.
  • The Current ratio of TN8 (1.89) is better than 68.18% of its industry peers.
  • A Quick Ratio of 1.53 indicates that TN8 should not have too much problems paying its short term obligations.
  • The Quick ratio of TN8 (1.53) is better than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.53
TN8.DE Yearly Current Assets VS Current LiabilitesTN8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

4

3. TN8.DE Growth Analysis

3.1 Past

  • TN8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.62%.
  • TN8 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.19% yearly.
  • TN8 shows a small growth in Revenue. In the last year, the Revenue has grown by 3.91%.
  • TN8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%

3.2 Future

  • Based on estimates for the next years, TN8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.80% on average per year.
  • The Revenue is expected to grow by 5.26% on average over the next years.
EPS Next Y8.45%
EPS Next 2Y8.79%
EPS Next 3Y9.32%
EPS Next 5Y10.8%
Revenue Next Year5.79%
Revenue Next 2Y5.45%
Revenue Next 3Y5.85%
Revenue Next 5Y5.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TN8.DE Yearly Revenue VS EstimatesTN8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B 50B
TN8.DE Yearly EPS VS EstimatesTN8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10 20 30 40

3

4. TN8.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.73, the valuation of TN8 can be described as rather expensive.
  • 63.64% of the companies in the same industry are more expensive than TN8, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.70. TN8 is around the same levels.
  • A Price/Forward Earnings ratio of 19.12 indicates a rather expensive valuation of TN8.
  • Based on the Price/Forward Earnings ratio, TN8 is valued a bit cheaper than 63.64% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of TN8 to the average of the S&P500 Index (23.84), we can say TN8 is valued inline with the index average.
Industry RankSector Rank
PE 20.73
Fwd PE 19.12
TN8.DE Price Earnings VS Forward Price EarningsTN8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TN8 is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TN8 indicates a somewhat cheap valuation: TN8 is cheaper than 68.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28
EV/EBITDA 18.99
TN8.DE Per share dataTN8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.45
PEG (5Y)6.51
EPS Next 2Y8.79%
EPS Next 3Y9.32%

3

5. TN8.DE Dividend Analysis

5.1 Amount

  • TN8 has a yearly dividend return of 0.36%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.45, TN8 has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, TN8's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.36%

5.2 History

  • The dividend of TN8 is nicely growing with an annual growth rate of 14.67%!
Dividend Growth(5Y)14.67%
Div Incr Years4
Div Non Decr Years4
TN8.DE Yearly Dividends per shareTN8.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 9.49% of the earnings are spent on dividend by TN8. This is a low number and sustainable payout ratio.
  • TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.49%
EPS Next 2Y8.79%
EPS Next 3Y9.32%
TN8.DE Yearly Income VS Free CF VS DividendTN8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
TN8.DE Dividend Payout.TN8.DE Dividend Payout, showing the Payout Ratio.TN8.DE Dividend Payout.PayoutRetained Earnings

TN8.DE Fundamentals: All Metrics, Ratios and Statistics

THERMO FISHER SCIENTIFIC INC

FRA:TN8 (3/13/2026, 7:00:00 PM)

410.75

-3.4 (-0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners95.38%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap152.59B
Revenue(TTM)44.56B
Net Income(TTM)6.70B
Analysts83.03
Price Target569.12 (38.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.36%
Yearly Dividend1.45
Dividend Growth(5Y)14.67%
DP9.49%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.64%
Min EPS beat(2)0.91%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.7%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)6
Avg EPS beat(8)2.42%
EPS beat(12)7
Avg EPS beat(12)1.02%
EPS beat(16)11
Avg EPS beat(16)2.83%
Revenue beat(2)2
Avg Revenue beat(2)1.08%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.21%
Revenue beat(4)4
Avg Revenue beat(4)0.77%
Min Revenue beat(4)0.28%
Max Revenue beat(4)1.21%
Revenue beat(8)6
Avg Revenue beat(8)0.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.27%
Revenue beat(16)11
Avg Revenue beat(16)1.95%
PT rev (1m)-0.47%
PT rev (3m)5.97%
EPS NQ rev (1m)-0.31%
EPS NQ rev (3m)-6.09%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)-0.2%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 20.73
Fwd PE 19.12
P/S 3.95
P/FCF 28
P/OCF 22.54
P/B 3.3
P/tB N/A
EV/EBITDA 18.99
EPS(TTM)19.81
EY4.82%
EPS(NY)21.48
Fwd EY5.23%
FCF(TTM)14.67
FCFY3.57%
OCF(TTM)18.23
OCFY4.44%
SpS103.87
BVpS124.51
TBVpS-27.49
PEG (NY)2.45
PEG (5Y)6.51
Graham Number235.58
Profitability
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROCE 8.52%
ROIC 6%
ROICexc 6.71%
ROICexgc 28.75%
OM 18.19%
PM (TTM) 15.05%
GM 41.09%
FCFM 14.12%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)6.18%
ROIC(5y)6.93%
ROICexc(3y)6.79%
ROICexc(5y)7.57%
ROICexgc(3y)30.99%
ROICexgc(5y)35.86%
ROCE(3y)8.78%
ROCE(5y)9.93%
ROICexgc growth 3Y-13.91%
ROICexgc growth 5Y-12.87%
ROICexc growth 3Y-6.93%
ROICexc growth 5Y-10.12%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-1.04%
GM growth 5Y-3.78%
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Debt/EBITDA 3.29
Cap/Depr 54.86%
Cap/Sales 3.42%
Interest Coverage 5.03
Cash Conversion 71.82%
Profit Quality 93.87%
Current Ratio 1.89
Quick Ratio 1.53
Altman-Z 3.42
F-Score5
WACC10.43%
ROIC/WACC0.58
Cap/Depr(3y)47.77%
Cap/Depr(5y)61.4%
Cap/Sales(3y)3.38%
Cap/Sales(5y)4.31%
Profit Quality(3y)108.04%
Profit Quality(5y)102.29%
High Growth Momentum
Growth
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
EPS Next Y8.45%
EPS Next 2Y8.79%
EPS Next 3Y9.32%
EPS Next 5Y10.8%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%
Revenue Next Year5.79%
Revenue Next 2Y5.45%
Revenue Next 3Y5.85%
Revenue Next 5Y5.26%
EBIT growth 1Y5.05%
EBIT growth 3Y-1.59%
EBIT growth 5Y0.61%
EBIT Next Year19.1%
EBIT Next 3Y11.62%
EBIT Next 5Y10.22%
FCF growth 1Y-13.4%
FCF growth 3Y-3.07%
FCF growth 5Y-1.58%
OCF growth 1Y-9.8%
OCF growth 3Y-5.12%
OCF growth 5Y-1.16%

THERMO FISHER SCIENTIFIC INC / TN8.DE FAQ

What is the fundamental rating for TN8 stock?

ChartMill assigns a fundamental rating of 4 / 10 to TN8.DE.


What is the valuation status for TN8 stock?

ChartMill assigns a valuation rating of 3 / 10 to THERMO FISHER SCIENTIFIC INC (TN8.DE). This can be considered as Overvalued.


What is the profitability of TN8 stock?

THERMO FISHER SCIENTIFIC INC (TN8.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for TN8 stock?

The financial health rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 5 / 10.


Can you provide the dividend sustainability for TN8 stock?

The dividend rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 3 / 10 and the dividend payout ratio is 9.49%.